The closing date for submissions was Friday, 16 April 2010

Clinical trials of medicines, medical devices, and other therapies are intended primarily to benefit those suffering ill health. They are also beneficial to clinicians, medical scientists, innovators, and health standards in the country in which they are carried out. There are also potential downsides, for example for a patient who is in the control group or experiences side effects. Currently Phase 1 - 1V trials have been estimated to be worth between $12 million to $30 million per year in New Zealand, compared with Australia where they are worth $450 million. The committee is interested in submitters' views on these matters

The committee requires 2 copies of each submission if made in writing. Those wishing to include any information of a private or personal nature in a submission should first discuss this with the clerk of the committee, as submissions are usually released to the public by the committee. Those wishing to appear before the committee to speak to their submissions should state this clearly and provide a daytime telephone contact number. To assist with administration please supply your postcode and an email address if you have one.

Further guidance on making a submission can be found from the Making a Submission to a Parliamentary Select Committee link in the `Related documents´ panel.